Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-25-009068

Options or other derivatives

  • EVP, Head of Research & Dev acquired 118,256 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2025-03-24 Grant or award · Stock Option (Right to Buy) +91,395 91,395 D
Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2025-03-24 Grant or award · Restricted Stock Units +26,861 26,861 D
Loading xslF345X05/form4-03262025_110352.xml…